EH
MRNA icon

Equitable Holdings’s Moderna MRNA Stock Holding History

Equitable Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
+3,041
New +$157K ﹤0.01% 1684
2022
Q1 		– Sell
-1,135
Closed -$288K – 901
2021
Q4 		$288K Buy
1,135
+487
+75% +$142K ﹤0.01% 719
2021
Q3 		$249K Sell
648
-537
-45% -$198K ﹤0.01% 730
2021
Q2 		$278K Buy
+1,185
New +$212K ﹤0.01% 687

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Equitable Holdings's MRNA Position: Q2 2026 in Review

Equitable Holdings opened a new position in Moderna (MRNA) in Q2 2026: 3,041 shares worth $213K. The stake represents ﹤0.01% of the portfolio and ranks #1684 among its holdings. This is a return to the name: Equitable Holdings previously reported a position in MRNA as recently as Q4 2021.

Equitable Holdings first reported a position in MRNA in Q2 2021 and has held it in 4 quarters since. The position peaked at $288K in Q4 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Equitable Holdings held 3,041 shares of Moderna worth $213K as of Q2 2026.
  • Moderna was a new Equitable Holdings position in Q2 2026.
  • Moderna made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1684 holding.
  • Equitable Holdings first reported a position in Moderna in Q2 2021 and has held it in 4 quarters since.
  • Equitable Holdings's Moderna position peaked at $288K in Q4 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.